United States· US:66738-161_3e0f654a-4144-ef80-e063-6394a90acf6e
Jack Black
A medicinal product containing petrolatum; avobenzone; homosalate; octisalate, registered in United States by Jack Black L.L.C..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- PETROLATUM; AVOBENZONE; HOMOSALATE; OCTISALATE
- Manufacturer
- Jack Black L.L.C.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1166738-161-01
- ndc1166738161011 TUBE in 1 CARTON (66738-161-01) / 7 mL in 1 TUBE (66738-161-21)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dc807159-8b19-476a-bc72-227ca2c7d2e6 GET /v1/drugs/dc807159-8b19-476a-bc72-227ca2c7d2e6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "40.2; 3; 5; 5",
"substance": "PETROLATUM; AVOBENZONE; HOMOSALATE; OCTISALATE",
"productndc": "66738-161",
"dosage_form": "OINTMENT",
"dea_schedule": null,
"strength_unit": "g/100mL; g/100mL; g/100mL; g/100mL",
"application_number": "M020",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about petrolatum; avobenzone; homosalate; octisalate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.